Neil Mathews

Neil has 20 years experience as a medicinal chemist in the pharma industry, across receptor, enzyme, kinase and antiviral targets. After a PhD at Imperial College and a postdoc year in Paris, Neil joined The Wellcome Foundation at Beckenham before moving to Stevenage as a group leader as it became GlaxoWellcome. At the time of the transition to GSK, Neil left to join Arrow Therapeutics where he led the Lead Optimisation group and managed the HCV projects up to and through their acquisition by AstraZeneca. Neil has a thorough understanding of the compound quality required by large pharma in-licensing groups at all stages of early development.

Neil Mathews is the Founder and Project Director at ReViral, based in Europe. With a background in Biotechnology, Neil Mathews has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.